Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study – first update

Título: Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study – first update
Resumen:Este documento informa de las estimaciones agrupadas del estudio del ECDC sobre la eficacia de la vacuna COVID-19, realizado mediante la aplicación de un enfoque multinacional utilizando el "Protocolo básico para los estudios del ECDC sobre la eficacia de la vacuna COVID-19 contra la hospitalización por infección respiratoria aguda grave confirmada por laboratorio con SARS-CoV-2, versión 1.0"

Summary:This document reports the pooled estimates from the ECDC study of COVID-19 vaccine effectiveness, conducted through the implementation of a multi-country approach using the 'Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory confirmed with SARS-CoV-2, version 1.0'.

Fecha publicación: 20-01-2022
Autor: Centro Europeo para la Prevención y el Control de las Enfermedades
ISBN / ISSN: 
Link: https://bit.ly/3AvSkfF
Palabras clave: coronavirus, COVID-19, UE, vacuna COVID-19
Keywords: coronavirus, COVID-19, EU, cholera, COVID-19 vaccine